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 BOnE BiOLOgY
Bone mineral as a drug- seeking moiety 
and a waste dump
a Review
Bone is a dynamic tissue with a quarter of the trabecular and a fifth of the cortical bone being 
replaced continuously each year in a complex process that continues throughout an individu-
al’s lifetime. Bone has an important role in homeostasis of minerals with non- stoichiometric hy-
droxyapatite bone mineral forming the inorganic phase of bone. Due to its crystal structure and 
chemistry, hydroxyapatite (HA) and related apatites have a remarkable ability to bind molecules. 
This review article describes the accretion of trace elements in bone mineral giving a historical 
perspective. Implanted HA particles of synthetic origin have proved to be an efficient recruiting 
moiety for systemically circulating drugs which can locally biomodulate the material and lead to a 
therapeutic effect. Bone mineral and apatite however also act as a waste dump for trace elements 
and drugs, which significantly affects the environment and human health.
Cite this article: Bone Joint Res 2020;9(10):709–718.
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Article focus
 This review article provides a historical back-
ground on the structure of the bone mineral 
hydroxyapatite (Ha) and its capacity to bind 
different agents.
 The article explores how different chemicals 
bind to Ha and the concomitant effect on 
human health and the environment.
Key messages
 Due to the chemical affinity of a broad 
spectrum of drugs (including antibiotics, 
bisphosphonates, and radioactive tracers) 
to Ha, it acts as a recruiting platform for 
systemically administered agents resulting 
in local targeted drug delivery.
 Ha also acts as a waste dump for several 
agents in nature and the human body, 
leading to unwanted harmful side- effects.
 Stringent measures should be taken to 
measure the accretion and safety of contam-
inants in bone mineral.
Strengths and limitations
 an innovative approach for drug accretion 
to particulate Ha is described.
 This article is not a systematic review but 
gives a perspective on how hydroxyap-
atite binds different agents and acts as a 
recruiting moiety.
introduction
apatite is a generic name for a large group 
of phosphate- containing minerals, essen-
tial to providing structural support in living 
and dead material in nature. apatite existed 
before life started and was a prerequi-
site for the evolution of single cell organ-
isms into vertebrates. Hydroxy(l)apatite 
(Ha – Ca5(PO4)3(OH)), often stated as 
Ca10(PO4)6(OH)2 due to its hexagonal crys-
tallographic symmetry, is the stoichiometric 
form of the inorganic mineral phase in bone 
and tooth (Figure  1a). Stoichiometric Ha is 
rare in nature; geologically fluorapatite (FaP, 
Ca5(PO4)3F), chlorapatite (CaP, Ca5(PO4)3Cl), 
and multiple substituted apatites are found 
in rocks and corals.1,2 More than 300 apatite- 
type minerals exist, with elements from the 
entire periodic table replacing Ca, P, and 
OH in the fundamental apatite crystal struc-
ture.3 in mammalian bone and teeth, further 
substitutions are found, including both a and 
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Fig. 1
Hydroxyapatite (Ha) structure and speculated mechanism of apatite deposition in bone. a) Unit cell of Ha in the (001) plane (reproduced with permission 
from the iCRP (Fihri a, Len C, varma RS, Solhy a. Hydroxyapatite: a review of syntheses, structure and applications in heterogeneous catalysis. Coordination 
Chemistry Reviews. 2017;347:48-76).6 b) Possible mechanism of Ha deposition by osteoblasts in the form of round vesicles (i) containing amorphous calcium 
phosphate nano- crystals. These vesicles infiltrate the collagen matrix and embed themselves (ii) where they undergo a step- growth (iii) from amorphous 
calcium phosphate (aCP) to crystalline Ha. Finally, (iv) the apatite crystals are elongated and aligned with the long axis of the collagen fibers (reproduced 
from Lotsari a, Rajasekharan aK, Halvarsson M, andersson M. Transformation of amorphous calcium phosphate to bone- like apatite. Nat Commun. 
2018;9(1):4170.7 Ca, calcium; P, phosphorus; O, oxygen; OH, hydroxyl.
B position carbonate substituted apatites (Ca10[(PO4)6- 
y(CO3)y][(OH)2- 2x(CO3)x]).
4,5
Human bone consists of approximately 55% minerals, 
35% collagen, and 10% water by weight.8 The mean 
annual bone turnover in a healthy adult has been 
approximated to be about 3.6% with clear differences 
between cortical and metaphyseal bone as reported by 
the international Commission on Radiological Protection 
in 1972.9 The process is continual and is started by osteo-
clast progenitors cleaning up old or damaged bone by 
a series of acidic and enzymatic treatments of old bone/
bone mineral followed by infiltration of osteoprogenitor 
cells differentiating into Ha- producing osteoblasts. Ha 
is formed within the collagen fibrils down at the atomic 
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Fig. 2
Rendering of the Rubia tinctorum (the rose madder) by Franz eugen Köhler 
(Original source: Köhlers Medizinal Pflanzen, 1897).
scale.7 Cells send out vesicles containing calcium and 
phosphate ions, deposited within the collagen network. 
a series of biochemical processes lead to the formation 
of an ordered, crystalline, but non- stoichiometric Ha 
structure (Figure  1b). The nano- apatite crystals located 
in the collagen fibrils however make detailed analysis of 
trace elements in bone mineral difficult. The mineral and 
collagen content are commonly not extracted directly 
from the bone, but from ash, which also contains trace 
elements from the collagen.
The most highly mineralized bone recorded, with a 
mineral content of 96%, is the rostrum (upper jaw bone) 
of the whale Mesoplodon densirostris, which can be 
used for understanding the chemistry of bone mineral.8 
Recently an extensive bone mineral content analysis 
was applied using both bulk analysis (radiograph fluo-
rescence, thermogravimetry, and carbon content) and 
elemental mapping (electron microprobe). These anal-
yses showed that the mineral in the rostrum on average 
had a composition of (Ca8.40Mg0.20Na0.54)[(PO4)4.87(CO3)1.13]
(OH)0.87, different from geological Ha (Ca10(PO4)6(OH)2) as 
the calcium is also replaced by magnesium and sodium 
while phosphate and hydroxyl groups are substituted by 
carbonate moieties as well.10
Tooth enamel is typically 97% mineral, 1% enam-
elin, a glycoprotein, and 3% water by weight.11,12 again, 
the mineral phase is rarely stoichiometric with the most 
common substitution being fluorine- forming fluorap-
atite, which better resists the development of caries by 
providing extra protection to the teeth in acidic condi-
tions.13 Dentine, the hard- inner structure of teeth, like 
bone, contains typically 40 vol% tooth mineral, which 
corresponds to 60 wt% mineral.14
Hydroxyapatite and its chemical interactions: 
a historical perspective
Besides being essential in high load- bearing structures 
like bones and teeth, Ha has a remarkable ability to bind 
molecules, owing to its crystal structure and chemistry. 
The first report of a substance binding to bone was by 
Leminus in 1567, describing that the root of the madder 
plant made bone red (Figure 2).15
almost 200 years later, Belchier in 1736 noticed at an 
evening dinner that the pork he was served had red bones 
and was later informed by the host that the pigs had 
been fed mashed madder root.15 This was the first report 
of a systemically administered agent traced in bone. 
John Hunter, in the late 1700s, studied bone growth by 
intermittent feeding of pigs with madder root.16 Hunter 
observed white and red bands in the growth zones of 
the pig mandible. More recently, Hoyte in the 1950s 
used alizarin (1,2- dihydroxyanthraquinone), an ingre-
dient of the madder root, for vital staining of bone.17 
Based on its interaction with bone, alizarin is still used 
today for dynamic histomorphometric studies of mineral 
apposition.17,18
apart from alizarin, several other substances have 
affinity for apatite. in 1935, while working with Niels Bohr 
(Nobel Prize winner in Physics, 1932) in Copenhagen, 
Georg de Hevesy, a Hungarian chemist, published the 
first study on radioactive bone mineral tracers in rats with 
32P sodium phosphate.19 The results showed dynamic 
bone turnover and continuous uptake of the phosphorus 
atoms. He is regarded as the founder of radioanalytical 
chemistry, radiograph fluorescence analysis, father of 
nuclear medicine, and received the 1942 Nobel Prize 
in Chemistry. in 1950 in Lund, Sweden, influenced by 
Niels Bohr and his son Hans Bohr, Göran Bauer, together 
with arvid Carlsson, the future 2002 Nobel Prize winner 
in Medicine, systemically administered a bone mineral- 
seeking radioactive tracer, 45Ca, to study bone accretion 
and metabolism.20,21 even before the availability of MRi 
and CT imaging, they and others used bone- seeking 
radioactive isotopes such as 85Sr for identifying bone turn-
over. This eventually paved the way for 99Tc scintigraphy, 
now commonly used for detection of osseous infections, 
tumours, or other metabolic disorders. Further, with the 
advancement in chemistry/radiosynthesis techniques 
and modern imaging equipment, the same tracer 99Tc 
has been coupled with hydroxy diphosphonate (99Tc- 
HDP) or methylene diphosphonate (99Tc- MDP) to study 
mineralization of human stem cells in vitro22 and bone 
turnover in vivo in humans.23
Hydroxyapatite as a drug-seeking moiety
The most well- known bone- seeking drugs are the 
bisphosphonates, and their therapeutic use was found 
by Herbert Fleisch in the 1960s.24 The bisphosphonates 
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Fig. 4
anteroposterior radiograph of an atypical femoral fracture caused by the 
prolonged use of bisphosphonates. Figure is reproduced from Lloyd et al.32
Fig. 3
Hydroxyapatite (Ha) as a recruiting platform for systemically circulating drugs in rats. a) Uptake of 14C- zoledronic acid (Za) in a pellet of calcium sulphate 
(CaS)/Ha implanted in the abdominal muscle pouch. Za was injected subcutaneously, two weeks post- implantation of CaS/Ha biomaterial and animals were 
euthanized 24 hours later. b) and c) show the uptake of antibiotic tetracycline (injected subcutaneously) and radioactive tracer 18F (intravenous injection) in 
a pellet of CaS/Ha biomaterial placed in the abdominal muscle pouch. Tetracycline uptake was measured using fluorescence microscopy while 18F uptake was 
accessed using positron emission tomography- CT. Figure has been modified from Raina et al.28
are synthetic, non- hydrolyzable analogues of inorganic 
pyrophosphates having carbon as a bridge between two 
phosphate groups, resulting in high mineral- binding 
capacity. Of the antiresorptive bisphosphonates avail-
able today, those containing nitrogen in the heterocy-
clic ring, for example zoledronic acid, are 10,000 times 
more potent than non- nitrogen- containing bisphos-
phonates.25,26 Bisphosphonates are today widely used 
for retarding osteoporosis by acting on osteoclasts and 
slowing bone resorption.25,27
in our own studies, we have recently implanted stoi-
chiometric synthetic particulate Ha in an ectopic muscle 
pouch model in rats.28 Two weeks later, the animals were 
systemically administered zoledronic acid (Za), which 
sought the Ha particles in the abdominal muscle pouch 
(Figure  3a).28 The Ha particles could even be reloaded 
and the local Za accretion in the implanted Ha pellet 
increased with reloading.
in another long- term in vivo study, radioactive Za 
was added to apatite particles implanted in osteopo-
rotic femoral necks in rats. Radioactive active Za was 
measured in the synthetic Ha particles as well as in the 
contralateral femur when the animals were euthanized at 
six months.29 it appears that bisphosphonates not only 
bind to the mineral, but remain bound in the bone for an 
extended period, potentially for years. The drug is even-
tually released in small amounts by osteoclast activity, 
only to be recirculated and rebound into vesicles that 
precipitate into new calcium phosphate mineral.
in several osteoporotic animal studies, we have 
administered Za both systemically and locally in multiple 
anatomical locations, but have never been able to show 
a positive effect on either bone formation or biomechan-
ical properties of Za on cortical bone30 unlike cancellous 
bone.31 in patients treated long- term with bisphospho-
nates, a rare complication is the atypical femoral fracture, 
a low- energy diaphyseal fracture in a weight- bearing 
limb (Figure  4).32 The probable cause is decelerated 
osteoclastic activity and delayed or even aborted bone 
remodelling which, without the natural bone repair 
system, allows a 'critical length' crack to develop in the 
cortical bone.
Antibiotics in bone mineral and infection
Tetracycline was the first antibiotic that was traced 
in bone after systemic administration as reported by 
andre33 in 1956. Fluorescence studies have later verified 
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Fig. 5
Bacterial attack on bone via the osteocyte lacunocanalicular network. 
a) and b) show transmission electron microscopy (TeM) images of the 
cortical bone from a mouse model of implant infection created using 
Staphyloccocus aureus. S. aureus develops an attack front to eradicate the 
bone lining cells (blue arrows) and embedding the osteocyte (OC). after 
compromising the cortical bone, the bacteria then colonize the osteocyte 
lacunocanalicular network (yellow arrow) and migrate within the canaliculi 
by expanding the structure to reach other osteocytes (red arrow in Fig. 5b). 
They simultaneously demineralize the bone matrix. c) an osteocyte lacuna 
inhabited by infiltrating S. aureus bacteria. Marker bars are: a) 5 µm (6,000× 
magnification); b) 10 µm (1,800× magnification); and c) 2 µm (12,000× 
magnification). image is reproduced from Masters et al.53
that bone, enamel, and dentine incorporate tetracycline, 
leading to discoloured teeth and bone in foetuses, chil-
dren, and adolescents.34,35 Perrin36 confirmed in 1967 
that tetracycline strongly binds to Ha, including mineral 
in dead bone, and proposed a chemical interaction 
between the mineral phase and tetracycline. Ha can also 
absorb tetracycline in solution.37 we have recently shown 
that systemically administered tetracycline is capable of 
seeking and binding to a microparticulate apatite moiety 
implanted in a muscle pouch (Figure 3b).28 Ha- binding 
substances can bind the substrate either by sequestering 
the calcium/phosphate ions or by forming hydrogen 
bonds.38 Hydrogen bonding can be efficient if the binding 
agent contains hydrophobic moieties. The affinity of an 
antibiotic to apatite particles would foremost depend 
on its chemical structure, i.e. binding capacity to the 
calcium, phosphate, and hydroxyl groups of Ha, and the 
number and size of the particles.
During the last 50 years, aseptic and antiseptic measures 
have focused on prevention and hindering bacteria from 
colonizing and forming biofilms on implanted devices.39 
if a deep bone or joint infection (DBJi) occurs, the implant 
is commonly removed and temporarily exchanged with 
an acrylate spacer containing very high levels of antibi-
otics such as gentamycin and vancomycin. Frequently, 
bacteria can still be found in the surrounding soft tissue 
and bone when the spacer is removed during a second 
stage, at prosthetic reimplantation.40 The costs associated 
with reoperations in the case of a revision total hip arthro-
plasty (THa) can be as high as £50,000 GBP, as recently 
reported by ahmed et al41 from the UK.
a novel treatment in DBJi is to implant a local micro-
particulate biphasic calcium sulphate- apatite carrier 
containing antibiotics, i.e. gentamycin or vancomycin, 
released in a targeted location in supraphysiological 
concentrations 100 to 1,000 times above the minimal 
inhibitory concentration (MiC) levels, but avoiding 
systemic side effects.42,43 The carrier is injectable and sets in 
situ in the defect created by radical surgical debridement. 
a success rate of up to 95% healing has been reported 
without infection recurrence in chronic longstanding 
osteomyelitis.44 Gentamycin and vancomycin, in contrast 
to tetracycline, do not bind to Ha, and consequently 
are completely released within a month, following the 
resorption of the soluble calcium sulphate (CaS) phase in 
the CaS/Ha carrier.42,43 even without the use of a carrier, 
prolonged use of antibiotics such as gentamycin or 
vancomycin have been reported to have no impact on 
bone turnover markers such as carboxy- terminal collagen 
crosslinks (CTX) or osteocalcin in humans.45 we have not 
been able to find any studies reporting a negative effect 
of long- term antibiotic usage or accumulation in bone 
with the exception of tetracycline. Recurrence of infection 
is reduced both in chronic osteomyelitis as well as in PJi, 
both with non- Ha- binding antibiotics such as penicillin46 
or with Ha- binding antibiotics such as rifampicin,47 even 
with prolonged treatment.
So far, no one has provided a full rationale as to why 
certain systemic antibiotic combinations have supe-
rior effect when it comes to biofilm- associated bone 
infections; we suggest that the reason could be the 
difference in antibiotic accretion in bone mineral.48 as 
a possible coincidence, the recommended and second 
level systemic antibiotics in DBJi, such as rifampicin and 
daptomycin, all have chemical structures that allow them 
to bind to apatite.
Qayoom et al49 recently reported in an in vitro study 
that rifampicin used for DBJi and tuberculosis, added to 
a biphasic calcium sulphate/Ha carrier, binds to the Ha 
phase. They found that 50% of the antibiotic remained in 
the material at three months, contrary to the non- binding 
anti- tuberculosis antibiotic isoniazid, which was released 
within the first month. This may explain the clinical ratio-
nale behind the proven efficacy of systemic antibiotic 
treatment in DBJi, using a combination of vancomycin/
gentamycin with rifampicin.50
it is well known that mycobacteria in bone tuberculosis 
can be dormant in their 'bone sarcophagus' for decades 
and then relapse. The senior author (LL) has in his clinical 
practice seen a tibial diaphyseal osteomyelitis recurring 
at the original location with Staphylococcus aureus after 
50 years of dormancy. in the literature, an osteomyelitis 
case was published with a genetically identical S. aureus 
strain recurring after 75 years of quiescence.51 The bone 
marrow, surrounding soft tissue, and the glycocalyx on 
the surface of implanted hardware are all well- known 
reservoirs for bacteria. Bacteria can also be internalized in 
bone cells such as osteoblasts or osteoclasts but probably 
only during the acute or subacute phases of an infection 
and generally do not persist.52 However, in long- standing 
chronic osteomyelitis, bacteria have recently been shown 
to reside sessile in the osteocyte- lacuna canalicular 
network (OLCN) in the cortical bone (Figure 5).53 This is 
a plausible long term 'hide away' and could explain why 
bacteria could survive in bone lifelong. This cortical bone 
OLCN sarcophagus needs to be opened and 'the sleeping 
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Fig. 6
anteroposterior radiographs showing the skeletal effects of fluoride poisoning through drinking water in humans. a) Knee deformity in a 12- year- old boy and 
b) fluoride- induced discolouration of teeth. c) and d) show radiographs of patients exposed to high fluoride levels showing dense sclerotic pelvic bone and 
spine. Unpublished images used with permission from Prof. Urban Rydholm, Lund University Hospital, Lund, Sweden.
beauty' i.e. dormant sessile bacteria attacked using new 
treatment methods.
a possible future development could be to use a 
local Ha or other calcium phosphate carriers preloaded 
or mixed with an Ha- binding antibiotic, and combine it 
with a non- binding antibiotic added to a material locally. 
an initial high, effective, and sustained local release of, for 
instance, gentamycin or vancomycin will be achieved.42,43 
By osteoclast resorption, a Ha- bound antibiotic, such as 
rifampicin or a tetracycline, will be continuously released 
in the OLCN and thereby poison the sessile bacteria in 
the cortical bone sarcophagus in the long term. even 
more intriguing is the recent finding that a local moiety 
containing tens of millions of Ha particles can be loaded 
and reloaded after implantation by systemic drug 
administration.28,54
Bone: a waste dump that affects health
Fluorosis an environmental bone dump disease. Fluorine 
binds rapidly to carbonated Ha in bone and is found in 
small amounts in nature, in ground water leaking out 
from fluorapatite (FaP) in rocks. Ha precursors are octa- 
calcium phosphate (OCP) and in the case of long- term 
high F− exposure, the F− ion will be accumulated into 
bone and teeth by the formation of fluorapatite (FaP) 
(Ca5(PO4)3F) instead of Ha.
55,56
Fluorine can in certain endemic areas reach toxic 
levels in drinking water resulting in severe growth defor-
mities in children (Figure 6a and 6b). in adults, fluorine 
causes 'marble bone disease' with severe secondary 
osteoarthritis (Figure 6c and 6d).57,58 The consumption of 
drinking water with a fluoride concentration higher than 
vOL. 9, NO. 10, OCTOBeR 2020
BONE MINERAL AS A DRUG- SEEKING MOIETY AND A WASTE DUMP 715
Fig. 7
image of a bleached coral reef in the Great Barrier Reef, courtesy of Jayne 
Jenkins, reproduced with permission.
the world Health Organization's (wHO) recommended 
limit of 1.5 mg/l59 is a health concern for more than 250 
million people today worldwide and an endemic causing 
serious disability in, for example, india.60 in many indus-
trial countries, although controversial,61 fluorine is added 
to drinking water. it is also an ingredient in toothpaste 
to reduce dental caries and recommended by dentists as 
mouthwash, especially for children. FaP is more resistant 
to the low pH produced by dental caries than Ha.
Triclosan and apatite: an environmental and health con-
cern? Triclosan (TC) is a phenyl ether with a broad anti-
bacterial spectrum widely used in soap, surgical sutures, 
toothpaste, deodorants, clothes, sun protectors, etc. 
The impact on health is the subject of debate - over- the- 
counter soap containing TC has been banned in the USa 
and Canada - as is the antibacterial effect of TC. There is 
no conclusive evidence that sutures containing TC have 
any effect on deep surgical site infection (SSi), and very 
limited evidence for preventing superficial infection. in 
2019 after a large randomized controlled trial, TC was not 
found to prevent superficial SSi and it was concluded that 
the use of TC- coated sutures in hip and knee arthroplasty 
does not lead to a reduction in the rate of SSi.62
in several studies, TC has been found in water,63 and in 
animal and human tissue.64 Ha has been shown to interact 
with TC via hydrogen bonding and electrostatic interac-
tions. Previously, Gilbert and watson65 showed that TC 
binds to saliva- coated enamel. Coral reefs, like bone, are 
made up of calcium derivates, mainly calcium carbonate, 
and it has been reported that sunscreen ingredients, 
including TC, accelerate coral bleaching (Figure 7).66 in 
2020 adamson and Shinkai67 reported that substances in 
common sun lotions are being absorbed through human 
skin. The reported blood levels exceeded Food and Drug 
administration (FDa) safety levels for several days.67,68 it 
was concluded that this needs to be investigated further 
to exclude any harmful effects. Countries with tourist 
beaches and coral reefs are therefore increasingly banning 
TC- containing sunscreens, to save the coral reefs.
in a large recent study, women with high TC levels 
in their urine, compared with those with low levels, 
suffered from osteoporosis as indicated by a low bone 
mineral density (BMD) at several anatomical locations.69 
The study does not prove a causal relation between TC in 
urine and osteoporosis, or the risk of sustaining a fragility 
fracture, and long- term prospective studies with multiple 
timepoints are needed, but an explanation could be that 
women with lower BMD may be in a catabolic phase due 
to increased osteoclast resorption releasing TC bound to 
apatite. TC chemically mimics oestrogen, thus affecting 
bone turnover. TC binding to Ha needs to be explored 
both in vitro as well as in vivo, and degradation and 
release measured. The level of TC in animal, human 
apatite, and coral apatite should be studied in exposed 
areas and compared to areas with non- contaminated 
water. in addition, the regulation of TC should be tight-
ened, at least in consumer goods.
Husbandry contaminating the environment and human 
bone mineral with antibiotics. Husbandry accounts for 
three- quarters of all antibiotics consumed. The rationale is 
mainly economical and aims to increase the weight and im-
prove the lives of cattle, pigs, and poultry.70 in recent years, 
farmed fish have been given antibiotics to reduce the infec-
tion burden during their short life cycle. Resistant bacteria, 
crossing over between husbandry and humans, have been 
documented: a recent analysis revealed that from 2000 
to 2018, the proportion of antimicrobials showing more 
than 50% resistance increased from 0.15 to 0.41 in chick-
ens, from 0.13 to 0.34 in pigs, and plateaued between 0.12 
and 0.23 in cattle.71 a global map based on data for the 
antibiotic use and development of resistance in husbandry 
is available and shows middle- income countries to be the 
worst affected (Figure  8).71 Resistant bacteria travel light 
and can cross borders without passports. Regulation has 
improved and in the USa, use of tetracycline, a common 
antibiotic used in cattle that is given at any time during the 
animal’s life cycle, has been reduced from 80% to 40%. in 
Germany, probably the most regulated country in europe, 
farming administers antibiotics seven times more often 
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Fig. 8
world map on antibiotic resistance from van Boeckel et al71. This map emphasizes P50, the proportion of bactericidal antibiotics which have a resistance 
above 50%. Only low- and middle- income countries are reported here. image is reproduced from van Boeckel et al with permission.71
than in Sweden, although still on a low level. in some coun-
tries tetracyclines are still routinely added to daily feeds. 
Tigecycline, a commonly used tetracycline, is also used in 
humans. The concern is that tetracyclines bind to Ha and 
remain in the bone for years.72 Thus, even if no antibiotic is 
given several weeks before slaughtering, the bone mineral 
remains loaded with antibiotics, which is highly relevant if 
the bone is industrially processed.
Bone settlers as waste dumpers. There is a large industri-
al sector with production based on the mineral and col-
lagen components of husbandry bone post mortem.73 
Collagen is extracted and used in several industrial pro-
cesses, including food production, as gelatine. For bone, 
heating to 200°C and/or acid softening is common, fol-
lowed by grinding into a bone powder. There are large 
differences in thermostability between antibiotics used 
in husbandry: for instance, doxycycline, another tetracy-
cline, remains stable even above 150°C.74 The bone meal 
is a valuable additive used in pet food and as fertilizer 
for vegetables.73 in some countries it is added as a meat 
expander/substitute in hamburgers.
There is a lack of studies on bone meal as a source of 
secondary antibiotic contamination, and a lack of data 
regarding degradation, release, and resistance pattern 
in humans, the soil, and water. There is also a dearth of 
research on trace elements bound to Ha in husbandry 
bone both in living animals and post mortem in the 
meat industry. we suggest that control of antibiotic food 
contamination extends to hard tissue, as well as the regu-
lation of the 'bone settlers' production technology.
Antibiotic water contamination - a harmful circle. The rise 
in antibiotic- resistant bacteria is a global health emergen-
cy that may kill ten million people by 2050, according to 
a UN report.75 in europe 33,000,76 and globally 700,000,75 
people were recently reported to die annually due to an 
antibiotic- resistant bacterial infection. Researchers recent-
ly tested 711 rivers and lakes in 72 countries and found 
antibiotics in 65% of them.77,78 in 111 of the sites, the con-
centrations of antibiotics exceeded safe levels, possibly 
contributing to the development of bacterial resistance. 
Lower- income countries generally had higher antibiotic 
concentrations in rivers and were often lacking the tech-
nology to remove the drugs.
Samples taken from rivers in europe, such as the Thames 
in the UK and the Danube in austria, also showed severe anti-
biotic contamination for seven antibiotics at nearly four- times 
the 'safe' level. at worst, it was 300 times over the safe limit 
in some rivers.78 Some concentrations are even so high that 
drinking three glasses daily from the Danube could poten-
tially be sufficient as oral antibiotic treatment for an upper 
respiratory infection. Some of the antibiotics, such as tetra-
cyclines, may again result in animals drinking the water with 
their bone reactive mineral phase acting as a waste dump. 
an antibiotic- induced minor change in the microbiome may 
increase the risk for an infection and postoperative DBJi.79
in conclusion, we have described novel binding mecha-
nisms for drug accretion to micro- and nano- apatite particles 
biologically activating the material. By systemic administra-
tion, pharmaceutical agents can seek and biomodulate a 
local moiety with apatite particles acting as a Trojan recharge-
able drug reservoir. The chemical interactions between 
specific drugs and apatite, including non- stoichiometric 
Ha found in bone, are however also responsible for a broad 
range of potential harmful effects. antibiotics adminis-
tered in husbandry pose considerable crossover risks of 
accrued drugs from animal bone to humans affecting the 
microbiome.
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